Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

References for PMC Articles for PubMed (Select 19638573)

1.

Role of neutrophils in BCG immunotherapy for bladder cancer.

Simons MP, O'Donnell MA, Griffith TS.

Urol Oncol. 2008 Jul-Aug;26(4):341-5. doi: 10.1016/j.urolonc.2007.11.031. Review.

2.

Twelve immunotherapy drugs that could cure cancers.

Cheever MA.

Immunol Rev. 2008 Apr;222:357-68. doi: 10.1111/j.1600-065X.2008.00604.x. Review.

PMID:
18364014
3.

Cancer statistics, 2008.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ.

CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.

4.

Controlled-release particulate cytokine adjuvants for cancer therapy.

Egilmez NK, Kilinc MO, Gu T, Conway TF.

Endocr Metab Immune Disord Drug Targets. 2007 Dec;7(4):266-70. Review.

PMID:
18220947
5.
6.

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).

Saban MR, Simpson C, Davis C, Wallis G, Knowlton N, Frank MB, Centola M, Gallucci RM, Saban R.

BMC Immunol. 2007 May 16;8:6.

7.
8.
9.

Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity.

Salem ML, Gillanders WE, Kadima AN, El-Naggar S, Rubinstein MP, Demcheva M, Vournakis JN, Cole DJ.

J Interferon Cytokine Res. 2006 Sep;26(9):593-608. Review.

PMID:
16978064
10.

Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy.

Loskog A, Ninalga C, Hedlund T, Alimohammadi M, Malmström PU, Tötterman TH.

Lab Anim. 2005 Oct;39(4):384-93.

PMID:
16197705
11.

The use of mucoadhesive polymers in vaginal delivery.

Valenta C.

Adv Drug Deliv Rev. 2005 Nov 3;57(11):1692-712. Epub 2005 Sep 22. Review.

PMID:
16182407
12.

Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model.

Horinaga M, Harsch KM, Fukuyama R, Heston W, Larchian W.

Urology. 2005 Aug;66(2):461-6.

PMID:
16040105
13.

Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences.

Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J.

J Immunol. 2005 Jul 1;175(1):342-9.

14.

Effective nasal influenza vaccine delivery using chitosan.

Read RC, Naylor SC, Potter CW, Bond J, Jabbal-Gill I, Fisher A, Illum L, Jennings R.

Vaccine. 2005 Aug 15;23(35):4367-74.

PMID:
15916838
15.

Chitosan: a versatile biopolymer for orthopaedic tissue-engineering.

Di Martino A, Sittinger M, Risbud MV.

Biomaterials. 2005 Oct;26(30):5983-90. Review.

PMID:
15894370
16.

Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium.

Kerec M, Bogataj M, Veranic P, Mrhar A.

Eur J Pharm Sci. 2005 May;25(1):113-21.

PMID:
15854807
17.

Global cancer statistics, 2002.

Parkin DM, Bray F, Ferlay J, Pisani P.

CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

PMID:
15761078
18.

Chitosan chemistry and pharmaceutical perspectives.

Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ.

Chem Rev. 2004 Dec;104(12):6017-84. Review. No abstract available.

PMID:
15584695
19.

Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.

Yu S, Zhao Y, Wu F, Zhang X, Lü W, Zhang H, Zhang Q.

Int J Pharm. 2004 Aug 20;281(1-2):11-23.

PMID:
15288339
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk